TrialAnnals of hematology2020

A phase II study of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin (ESHAOx) for patients with refractory or relapsed Hodgkin's lymphoma.

Young-Woong Won et al.PubMed ↗Publisher ↗

No numbers read from the abstract.